Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...

The company already had heart failure data on valsartan, which has been marketed for hypertension as Diovan for years, but he noted that "heart failure is not like blood pressure. I don't know ...

especially when used with the diuretic hydrochlorothiazide or with the ARB valsartan (Diovan; Novartis). Limited data is available on its use with other classes of antihypertensives, but intial ...

So read up on the things they want everyone to keep in mind to help protect your ticker. (And consider investing in one of ...

Bristol–Myers Squibb/Sanofi–Aventis), valsartan (Diovan; Novartis) and topiramate (Topamax; Johnson & Johnson) — are scheduled to go off-patent in the 2009E–2013E time frame. Moreover ...

Sandoz has announced a number of steps to resolve the US Generic Drug Antitrust Class Action Litigation. Following the previously announced settlements with the U.S. Department of Justice in 2020 ...